Your Epigenetic editors enter clinical trials.

Epigenetic editing could help people with Primary Immunodeficiency Disorders by regulating defective immune-related genes, enhancing expression of functional proteins, correcting signaling pathways, and reprogramming immune cells, offering precise, reversible, and targeted therapeutic options.

GENE THERAPY RESEARCH

https://www.chemistryworld.com/news/epigenetic-editors-enter-clinical-trials/4021267.article

4/10/20251 min read

My post content

Mission

Advancing research and education for Primary Immunodeficiency Disorders.
Research Alliance for Primary Immunodeficiency Discoveries (RAPID).

Contact

Support

info@rapidfoundation.org

© 2025. All rights reserved.